Table 3.
Proportion of patients switching class at 6 and at 12 months
| Antipsychotic treatment group switched to | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Switch From | % of patient switches at 6 months of continuous antipsychotic therapy | % of patient switches at 12 months of continuous antipsychotic therapy | ||||||||
| Atypical Oral | Atypical LAT | Typical Oral | Typical LAT | Clozapine | Atypical Oral | Atypical LAT | Typical Oral | Typical LAT | Clozapine | |
| Atypical Oral | - | 2% | 1% | 1% | <1% | - | 3% | 2% | 2% | <1% |
| Atypical LAT | 5% | - | 0% | 0% | 0% | 9% | - | 0% | 0% | 0% |
| Typical Oral | 11% | 0% | - | 26% | 0% | 16% | 0% | - | 31% | 0% |
| Typical LAT | 3% | 1% | 5% | - | 0% | 4% | 1% | 0% | - | 7% |
| Clozapine | 1% | 0% | 0% | 1% | - | 3% | 0% | 0% | 1% | - |